News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
879,488 Results
Type
Article (88561)
Company Profile (815)
Press Release (790079)
Multimedia
Podcasts (226)
Webinars (34)
Section
Business (233499)
Career Advice (4157)
Deals (39944)
Drug Delivery (172)
Drug Development (91606)
Employer Resources (207)
FDA (18511)
Job Trends (17469)
News (398496)
Policy (40011)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (39)
Allergies (183)
Alliances (56987)
ALS (219)
Alzheimer's disease (1920)
Antibody-drug conjugate (ADC) (487)
Approvals (18793)
Artificial intelligence (795)
Autoimmune disease (291)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (236)
Biotechnology (486)
Bladder cancer (194)
Brain cancer (80)
Breast cancer (780)
Cancer (6082)
Cardiovascular disease (518)
Career advice (3588)
Career pathing (48)
CAR-T (353)
CDC (74)
Celiac Disease (3)
Cell therapy (980)
Cervical cancer (48)
Clinical research (78300)
Collaboration (2226)
Company closure (8)
Compensation (1400)
Complete response letters (100)
COVID-19 (3024)
CRISPR (117)
C-suite (1165)
Cystic fibrosis (162)
Data (7832)
Decentralized trials (3)
Denatured (85)
Depression (184)
Dermatology (83)
Diabetes (627)
Diagnostics (7488)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (390)
Drug pricing (243)
Drug shortages (39)
Duchenne muscular dystrophy (296)
Earnings (101802)
Editorial (75)
Employer branding (25)
Employer resources (174)
Events (137313)
Executive appointments (1150)
FDA (22323)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1825)
Gene editing (256)
Generative AI (85)
Gene therapy (800)
GLP-1 (1235)
Government (5533)
Grass and pollen (8)
Guidances (408)
Healthcare (21074)
HIV (87)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (99)
Immunology and inflammation (341)
Immuno-oncology (99)
Indications (178)
Infectious disease (3396)
Inflammatory bowel disease (233)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (298)
Interviews (819)
IPO (17987)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (109)
Layoffs (675)
Leadership (48)
Legal (10171)
Liver cancer (107)
Longevity (35)
Lung cancer (802)
Lymphoma (433)
Machine learning (63)
Management (66)
Manufacturing (1110)
MASH (198)
Medical device (15213)
Medtech (15325)
Mergers & acquisitions (23199)
Metabolic disorders (1667)
mRNA (240)
Multiple sclerosis (194)
NASH (24)
Neurodegenerative disease (461)
Neuropsychiatric disorders (124)
Neuroscience (3545)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5135)
Now hiring (77)
Obesity (810)
Opinion (366)
Ovarian cancer (217)
Pain (270)
Pancreatic cancer (307)
Parkinson's disease (382)
Partnered (39)
Patents (618)
Patient recruitment (681)
Peanut (66)
People (67681)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24193)
Phase 2 (34005)
Phase 3 (25582)
Pipeline (8281)
Policy (380)
Postmarket research (3558)
Preclinical (10890)
Press Release (72)
Prostate cancer (310)
Psychedelics (66)
Radiopharmaceuticals (350)
Rare diseases (1171)
Real estate (7454)
Recruiting (81)
Regulatory (30013)
Reports (76)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (191)
Series A (310)
Series B (221)
Service/supplier (30)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (188)
Sponsored (54)
Startups (4361)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (138)
Vaccines (1260)
Venture capital (120)
Weight loss (559)
Women's health (128)
Worklife (24)
Date
Today (180)
Last 7 days (902)
Last 30 days (3153)
Last 365 days (33107)
2026 (11837)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1295)
Alabama (100)
Alaska (7)
Arizona (385)
Arkansas (16)
Asia (52034)
Australia (9153)
California (13441)
Canada (3800)
China (1417)
Colorado (578)
Connecticut (596)
Delaware (413)
Europe (119932)
Florida (1995)
Georgia (439)
Hawaii (4)
Idaho (69)
Illinois (1156)
India (97)
Indiana (629)
Iowa (25)
Japan (538)
Kansas (138)
Kentucky (56)
Louisiana (45)
Maine (87)
Maryland (1649)
Massachusetts (9818)
Michigan (405)
Minnesota (752)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (146)
New Hampshire (92)
New Jersey (3595)
New Mexico (33)
New York (3541)
North Carolina (1827)
North Dakota (10)
Northern California (6608)
Ohio (417)
Oklahoma (26)
Oregon (55)
Pennsylvania (2671)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5254)
Tennessee (214)
Texas (2173)
United States (48257)
Utah (401)
Vermont (1)
Virginia (345)
Washington D.C. (88)
Washington State (1112)
West Virginia (4)
Wisconsin (151)
Wyoming (2)
There are 879,488 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MASH
Madrigal picks up another siRNA asset for MASH, betting up to $1B with Arrowhead
Madrigal Pharmaceuticals has licensed from Arrowhead Pharmaceuticals an RNA interference candidate that targets a genetic mutation present in around 30% of patients with MASH.
May 5, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Altesa BioSciences Enrolls First Patient in Phase 2b CARDINAL Clinical Trial Evaluating Vapendavir as Transformational Treatment for Patients with COPD Impacted by Rhinovirus, the Leading Cause of Exacerbations
May 5, 2026
·
4 min read
Press Releases
FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from Fentanyl
May 5, 2026
·
2 min read
Press Releases
Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
May 5, 2026
·
10 min read
Press Releases
Longwood Healthcare Leaders to Host MIT CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders at MIT Koch Institute
May 5, 2026
·
3 min read
Press Releases
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
May 5, 2026
·
28 min read
Press Releases
Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)
May 5, 2026
·
11 min read
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
May 5, 2026
·
5 min read
Press Releases
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
May 5, 2026
·
20 min read
Press Releases
Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
May 5, 2026
·
1 min read
1 of 87,949
Next
